Gene · 4102
Papers3,353
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 3,353
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Toll-like receptor-targeted anti-tumor therapies: Advances and challenges. | Front Immunol | 2022 | 36479129 | PubTator, text mining | PubMed |
| Development of therapeutic vaccines for the treatment of diseases. | Mol Biomed | 2022 | 36477638 | PubTator, text mining | PubMed |
| Exploiting the potential of extracellular vesicles as delivery vehicles for the treatment of melanoma. | Front Bioeng Biotechnol | 2022 | 36466338 | PubTator, text mining | PubMed |
| Utilization of macrocyclic peptides to target protein-protein interactions in cancer. | Front Oncol | 2022 | 36465350 | PubTator, text mining | PubMed |
| Next-generation immunotherapy for solid tumors: combination immunotherapy with crosstalk blockade of TGFβ and PD-1/PD-L1. | Expert Opin Investig Drugs | 2022 | 36448335 | PubTator, text mining | PubMed |
| Cardiovascular effects associated with chimeric antigen receptor T cell therapy in cancer patients: A meta-analysis. | Front Oncol | 2022 | 36439485 | PubTator, text mining | PubMed |
| Lipid nanoparticles for delivery of RNA therapeutics: Current status and the role of in vivo imaging. | Theranostics | 2022 | 36438494 | PubTator, text mining | PubMed |
| Chromosomally Unstable Gastric Cancers Overexpressing Claudin-6 Disclose Cross-Talk between HNF1A and HNF4A, and Upregulated Cholesterol Metabolism. | Int J Mol Sci | 2022 | 36430456 | PubTator, text mining | PubMed |
| Signatures of Breast Cancer Progression in the Blood: What Could Be Learned from Circulating Tumor Cell Transcriptomes. | Cancers (Basel) | 2022 | 36428760 | PubTator, text mining | PubMed |
| Integrated Analysis of Single-Cell and Bulk RNA-Sequencing Reveals a Tissue-Resident Macrophage-Related Signature for Predicting Immunotherapy Response in Breast Cancer Patients. | Cancers (Basel) | 2022 | 36428599 | PubTator, text mining | PubMed |
| Advances in the Lung Cancer Immunotherapy Approaches. | Vaccines (Basel) | 2022 | 36423060 | PubTator, text mining | PubMed |
| Nucleic acid vaccination strategies for ovarian cancer. | Front Bioeng Biotechnol | 2022 | 36420446 | PubTator, text mining | PubMed |
| Liposomes and liposome-like nanoparticles: From anti-fungal infection to the COVID-19 pandemic treatment. | Asian J Pharm Sci | 2022 | 36415834 | PubTator, text mining | PubMed |
| Cancer-testis antigen lactate dehydrogenase C4 as a novel biomarker of male infertility and cancer. | Front Oncol | 2022 | 36408133 | PubTator, text mining | PubMed |
| Immunoinformatics Analysis of Citrullinated Antigen as Potential Multi-peptide Lung Cancer Vaccine Candidates for Indonesian Population. | Int J Pept Res Ther | 2022 | 36406283 | PubTator, text mining | PubMed |
| MatchTope: A tool to predict the cross reactivity of peptides complexed with Major Histocompatibility Complex I. | Front Immunol | 2022 | 36389840 | PubTator, text mining | PubMed |
| Interim efficacy and safety of PD-1 inhibitors in preventing recurrence of hepatocellular carcinoma after interventional therapy. | Front Immunol | 2022 | 36389724 | PubTator, text mining | PubMed |
| Immunotherapy for the treatment of multiple myeloma. | Front Immunol | 2022 | 36389674 | PubTator, text mining | PubMed |
| Immunotherapy response and microenvironment provide biomarkers of immunotherapy options for patients with lung adenocarcinoma. | Front Genet | 2022 | 36386793 | PubTator, text mining | PubMed |
| MAGE-A3 regulates tumor stemness in gastric cancer through the PI3K/AKT pathway. | Aging (Albany NY) | 2022 | 36367777 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4102/papers?page=20